T2 BIOSYSTEMS INC (TTOO)

US89853L3024 - Common Stock

0.42  -0.01 (-1.18%)

After market: 0.4126 -0.01 (-1.76%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
28.06M
54.77%
22.31M
-20.49%
7.193M
-67.76%
10.812M
50.31%
23.562M
117.92%
33.966M
44.16%
47.124M
38.74%
62.22M
32.03%
80.07M
28.69%
98.124M
22.55%
112.81M
14.97%
EBITDA
YoY % growth
-41.7M
-8.17%
-54.15M
-29.86%
-46.294M
14.51%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
-42.97M
-6.73%
-55.2M
-28.46%
-47.153M
14.58%
-42.228M
10.44%
-39.576M
6.28%
-38.046M
3.87%
-41.616M
-9.38%
-33.762M
18.87%
-21.624M
35.95%
-13.566M
37.26%
-5.304M
60.90%
Operating Margin
-153.14%-247.42%-655.54%-390.57%-167.97%-112.01%-88.31%-54.26%-27.01%-13.83%-4.70%
EPS
YoY % growth
-361.50
-1,471.74%
-1,436.00
-297.23%
N/A
98.68%
-3.16
83.26%
-1.21
61.61%
-0.71
41.18%
-0.57
20.00%
-0.38
33.93%
-0.22
40.54%
N/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.60
73.18%
-0.49
81.59%
-0.40
39.73%
-0.33
50.00%
-0.28
54.24%
Revenue
Q2Q % growth
3.672M
118.70%
4.488M
117.76%
5.304M
171.72%
6.324M
218.59%
7.548M
105.56%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-11.832M
-26.97%
-11.934M
5.29%
-12.036M
-25.70%
-11.934M
-17.45%
-11.73M
0.86%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth

81.08%
-0.65%
Q2 2024
Q2Q % growth
-0.66
91.75%
-0.990.3333.29%
Q1 2024
Q2Q % growth
-2.66
97.98%
-1.90-0.76-40.21%
Q4 2023
Q2Q % growth

98.41%
-2.24%
Q3 2023
Q2Q % growth
-3.45
98.83%
-3.930.4812.15%
Q2 2023
Q2Q % growth
-8.00
98.40%
-27.2019.2070.59%
Q1 2023
Q2Q % growth
-132.00
73.60%
-122.74-9.26-7.54%
Q4 2022
Q2Q % growth
-141.00
59.71%
-173.9132.9118.92%
Q3 2022
Q2Q % growth
-295.00
-7,275.00%
-208.42-86.58-41.54%
Q2 2022
Q2Q % growth
-500.00
-12,400.00%
-459.00-41.00-8.93%
Q1 2022
Q2Q % growth
-500.00
-14,185.71%
-382.50-117.50-30.72%
Q4 2021
Q2Q % growth
-350.00
-9,900.00%
-459.00109.0023.75%
Q3 2021
Q2Q % growth
-4.00 -4.340.337.73%
Q2 2021
Q2Q % growth
-4.00
11.11%
-4.080.081.96%
Q1 2021
Q2Q % growth
-3.50
68.18%
-3.770.277.26%
Q4 2020
Q2Q % growth
-3.50
75.86%
-3.47-0.03-0.92%
Q3 2020
Q2Q % growth
-4.00
74.19%
-3.98-0.02-0.55%
Q2 2020
Q2Q % growth
-4.50
74.29%
-7.653.1541.18%
Q1 2020
Q2Q % growth
-11.00
35.29%
-11.990.988.22%
Q4 2019
Q2Q % growth
-14.50 -13.86-0.64-4.65%
Q3 2019
Q2Q % growth
-15.50 -16.741.247.43%
Q2 2019
Q2Q % growth
-17.50 -16.45-1.05-6.40%
Q1 2019
Q2Q % growth
-17.00 -15.37-1.63-10.58%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
1.985M
34.85%
2.856M-871K-30.50%
Q2 2024
Q2Q % growth
1.952M
-0.61%
2.142M-190K-8.87%
Q1 2024
Q2Q % growth
2.061M
-0.82%
1.632M429K26.29%
Q4 2023
Q2Q % growth
1.679M
-69.36%
2.04M-361K-17.70%
Q3 2023
Q2Q % growth
1.472M
-60.00%
1.53M-58K-3.79%
Q2 2023
Q2Q % growth
1.964M
-66.77%
2.074M-110K-5.30%
Q1 2023
Q2Q % growth
2.078M
-71.26%
2.38M-302K-12.69%
Q4 2022
Q2Q % growth
5.48M
-21.49%
5.508M-28K-0.51%
Q3 2022
Q2Q % growth
3.68M
-50.47%
6.018M-2.338M-38.85%
Q2 2022
Q2Q % growth
5.91M
-11.66%
6.256M-346K-5.53%
Q1 2022
Q2Q % growth
7.23M
3.88%
6.783M447K6.59%
Q4 2021
Q2Q % growth
6.98M
-10.40%
6.299M681K10.81%
Q3 2021
Q2Q % growth
7.43M
41.52%
5.814M1.616M27.79%
Q2 2021
Q2Q % growth
6.69M
162.35%
6.256M434K6.94%
Q1 2021
Q2Q % growth
6.96M
172.94%
6.565M395K6.02%
Q4 2020
Q2Q % growth
7.79M
153.75%
8.116M-326K-4.02%
Q3 2020
Q2Q % growth
5.25M
212.50%
5.244M6K0.11%
Q2 2020
Q2Q % growth
2.55M
41.67%
2.414M136K5.63%
Q1 2020
Q2Q % growth
2.55M
42.46%
2.688M-138K-5.13%
Q4 2019
Q2Q % growth
3.07M 3.749M-679K-18.11%
Q3 2019
Q2Q % growth
1.68M 1.925M-245K-12.73%
Q2 2019
Q2Q % growth
1.8M 2.042M-242K-11.85%
Q1 2019
Q2Q % growth
1.79M 1.422M368K25.88%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% 0%
Revenue0% 0% 0% 0%